Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Accelerating the development of biomarkers for drug safety [[electronic resource] ] : workshop summary / / Steve Olson, Sally Robinson and Robert Giffin, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
| Accelerating the development of biomarkers for drug safety [[electronic resource] ] : workshop summary / / Steve Olson, Sally Robinson and Robert Giffin, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies |
| Pubbl/distr/stampa | Washington, D.C., : National Academies Press, c2009 |
| Descrizione fisica | 1 online resource (99 p.) |
| Disciplina | 616.075 |
| Altri autori (Persone) |
GiffinRobert B
OlsonSteve <1956-> RobinsonSally |
| Soggetto topico |
Biochemical markers
Drugs - Safety measures Drugs - Testing |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-282-27265-9
9786612272653 0-309-13125-1 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910454905103321 |
| Washington, D.C., : National Academies Press, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Accelerating the development of biomarkers for drug safety [[electronic resource] ] : workshop summary / / Steve Olson, Sally Robinson and Robert Giffin, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
| Accelerating the development of biomarkers for drug safety [[electronic resource] ] : workshop summary / / Steve Olson, Sally Robinson and Robert Giffin, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies |
| Pubbl/distr/stampa | Washington, D.C., : National Academies Press, c2009 |
| Descrizione fisica | 1 online resource (99 p.) |
| Disciplina | 616.075 |
| Altri autori (Persone) |
GiffinRobert B
OlsonSteve <1956-> RobinsonSally |
| Soggetto topico |
Biochemical markers
Drugs - Safety measures Drugs - Testing |
| ISBN |
0-309-14231-8
1-282-27265-9 9786612272653 0-309-13125-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Overview Of key issues -- Cardiac safety biomarkers -- Assessing and predicting kidney safety -- Biomarkers of acute idiosyncratic hepatocellular injury in clinical trials -- Future considerations. |
| Record Nr. | UNINA-9910778330203321 |
| Washington, D.C., : National Academies Press, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Accelerating the development of biomarkers for drug safety : workshop summary / / Steve Olson, Sally Robinson and Robert Giffin, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
| Accelerating the development of biomarkers for drug safety : workshop summary / / Steve Olson, Sally Robinson and Robert Giffin, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Washington, D.C., : National Academies Press, c2009 |
| Descrizione fisica | 1 online resource (99 p.) |
| Disciplina | 616.075 |
| Altri autori (Persone) |
GiffinRobert B
OlsonSteve <1956-> RobinsonSally |
| Soggetto topico |
Biochemical markers
Drugs - Safety measures Drugs - Testing |
| ISBN |
0-309-14231-8
1-282-27265-9 9786612272653 0-309-13125-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Overview Of key issues -- Cardiac safety biomarkers -- Assessing and predicting kidney safety -- Biomarkers of acute idiosyncratic hepatocellular injury in clinical trials -- Future considerations. |
| Record Nr. | UNINA-9910828713903321 |
| Washington, D.C., : National Academies Press, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Addressing the threat of drug-resistant tuberculosis [[electronic resource] ] : a realistic assessment of the challenge : workshop summary / / Robert Giffin and Sally Robinson, rapporteurs; Institute of Medicine of the National Academies
| Addressing the threat of drug-resistant tuberculosis [[electronic resource] ] : a realistic assessment of the challenge : workshop summary / / Robert Giffin and Sally Robinson, rapporteurs; Institute of Medicine of the National Academies |
| Pubbl/distr/stampa | Washington, D.C., : National Academies Press, 2009 |
| Descrizione fisica | 1 online resource (253 p.) |
| Disciplina | 616.9 |
| Altri autori (Persone) |
GiffinRobert B
RobinsonSally |
| Soggetto topico |
Multidrug-resistant tuberculosis
Tuberculosis Drug resistance Antitubercular agents |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-282-45484-6
9786612454844 0-309-13045-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Reviewers""; ""Contents""; ""Tables, Figures, and Boxes""; ""Acronyms""; ""Summary""; ""1 Introduction""; ""2 The Global Spread of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis""; ""3 MDR TB Transmission, HIV Coinfection, and Transmission Control""; ""4 Diagnosis""; ""5 Infrastructure and Health Care Delivery Systems""; ""6 Global Systems for the Purchase and Delivery of TB Drugs""; ""7 Research on the Global Control of TB: Understanding the Role of Drugs, Vaccines, and Funding""; ""8 Strategies for Confronting the Global MDR and XDR TB Crisis""; ""References""
""Appendix A: Agenda""""Appendix B: Participant Biographies""; ""Appendix C: Partners In Health White Paper�Stemming the Tide of Multidrug-Resistant Tuberculosis: Major Barriers to Addressing the Growing Epidemic"" |
| Record Nr. | UNINA-9910456590803321 |
| Washington, D.C., : National Academies Press, 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Addressing the threat of drug-resistant tuberculosis [[electronic resource] ] : a realistic assessment of the challenge : workshop summary / / Robert Giffin and Sally Robinson, rapporteurs; Institute of Medicine of the National Academies
| Addressing the threat of drug-resistant tuberculosis [[electronic resource] ] : a realistic assessment of the challenge : workshop summary / / Robert Giffin and Sally Robinson, rapporteurs; Institute of Medicine of the National Academies |
| Pubbl/distr/stampa | Washington, D.C., : National Academies Press, 2009 |
| Descrizione fisica | 1 online resource (253 p.) |
| Disciplina | 616.9 |
| Altri autori (Persone) |
GiffinRobert B
RobinsonSally |
| Soggetto topico |
Multidrug-resistant tuberculosis
Tuberculosis Drug resistance Antitubercular agents |
| ISBN |
0-309-14874-X
1-282-45484-6 9786612454844 0-309-13045-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Reviewers -- Contents -- Tables, Figures, and Boxes -- Acronyms -- Summary -- Chapter 1. Introduction -- Chapter 2. The Global Spread of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis -- Chapter 3. MDR TB Transmission, HIV Coinfection, and Transmission Control -- Chapter 4. Diagnosis -- Chapter 6. Infrastructure and Health Care Delivery Systems -- 6 Global Systems for the Purchase and Delivery of TB Drugs -- Chapter 7. Research on the Global Control of TB: Understanding the Role of Drugs, Vaccines, and Funding -- Chapter 8. Strategies for Confronting the Global MDR and XDR TB Crisis -- References. -- Appendix A: Agenda -- Appendix B: Participant Biographies -- Appendix C: Partners In Health White Paper' stemming the Tide of Multidrug-Resistant Tuberculosis: Major Barriers to Addressing the Growing Epidemic -- |
| Record Nr. | UNINA-9910781187903321 |
| Washington, D.C., : National Academies Press, 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Addressing the threat of drug-resistant tuberculosis : a realistic assessment of the challenge : workshop summary / / Robert Giffin and Sally Robinson, rapporteurs; Institute of Medicine of the National Academies
| Addressing the threat of drug-resistant tuberculosis : a realistic assessment of the challenge : workshop summary / / Robert Giffin and Sally Robinson, rapporteurs; Institute of Medicine of the National Academies |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Washington, D.C., : National Academies Press, 2009 |
| Descrizione fisica | 1 online resource (253 p.) |
| Disciplina | 616.9 |
| Altri autori (Persone) |
GiffinRobert B
RobinsonSally |
| Soggetto topico |
Multidrug-resistant tuberculosis
Tuberculosis Drug resistance Antitubercular agents |
| ISBN |
0-309-14874-X
1-282-45484-6 9786612454844 0-309-13045-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Reviewers -- Contents -- Tables, Figures, and Boxes -- Acronyms -- Summary -- Chapter 1. Introduction -- Chapter 2. The Global Spread of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis -- Chapter 3. MDR TB Transmission, HIV Coinfection, and Transmission Control -- Chapter 4. Diagnosis -- Chapter 6. Infrastructure and Health Care Delivery Systems -- 6 Global Systems for the Purchase and Delivery of TB Drugs -- Chapter 7. Research on the Global Control of TB: Understanding the Role of Drugs, Vaccines, and Funding -- Chapter 8. Strategies for Confronting the Global MDR and XDR TB Crisis -- References. -- Appendix A: Agenda -- Appendix B: Participant Biographies -- Appendix C: Partners In Health White Paper' stemming the Tide of Multidrug-Resistant Tuberculosis: Major Barriers to Addressing the Growing Epidemic -- |
| Record Nr. | UNINA-9910819902103321 |
| Washington, D.C., : National Academies Press, 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Breakthrough business models [[electronic resource] ] : drug development for rare and neglected diseases and individualized therapies : workshop summary / / Theresa Wizemann, Sally Robinson, and Robert Giffin ; Forum on Health Sciences Policy, Institute of Medicine of the National Academies
| Breakthrough business models [[electronic resource] ] : drug development for rare and neglected diseases and individualized therapies : workshop summary / / Theresa Wizemann, Sally Robinson, and Robert Giffin ; Forum on Health Sciences Policy, Institute of Medicine of the National Academies |
| Autore | Wizemann Theresa M |
| Pubbl/distr/stampa | Washington, D.C., : National Academies Press, 2009 |
| Descrizione fisica | 1 online resource (149 p.) |
| Disciplina | 615/.19 |
| Altri autori (Persone) |
WizemannTheresa M
RobinsonSally GiffinRobert B |
| Soggetto topico |
Orphan drugs - Government policy - United States
Pharmaceutical policy - United States Drugs - Design - United States |
| ISBN |
0-309-17816-9
1-282-08355-4 9786612083556 0-309-12089-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction and overview -- Current model for financing drug development : from concept through approval -- The Food and Drug Administration's Orphan Drug Program -- Diverse funding models -- Strategies for facilitating sharing of research materials and data -- Strategies of navigation intellectual property -- Strategies for facilitating clinical trials -- Summary. |
| Record Nr. | UNINA-9910777913803321 |
Wizemann Theresa M
|
||
| Washington, D.C., : National Academies Press, 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Breakthrough business models [[electronic resource] ] : drug development for rare and neglected diseases and individualized therapies : workshop summary / / Theresa Wizemann, Sally Robinson, and Robert Giffin ; Forum on Health Sciences Policy, Institute of Medicine of the National Academies
| Breakthrough business models [[electronic resource] ] : drug development for rare and neglected diseases and individualized therapies : workshop summary / / Theresa Wizemann, Sally Robinson, and Robert Giffin ; Forum on Health Sciences Policy, Institute of Medicine of the National Academies |
| Pubbl/distr/stampa | Washington, D.C., : National Academies Press, 2009 |
| Descrizione fisica | 1 online resource (149 p.) |
| Disciplina | 615/.19 |
| Altri autori (Persone) |
WizemannTheresa M
RobinsonSally GiffinRobert B |
| Soggetto topico |
Orphan drugs - Government policy - United States
Pharmaceutical policy - United States Drugs - Design - United States |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-282-08355-4
9786612083556 0-309-12089-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910454529203321 |
| Washington, D.C., : National Academies Press, 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Breakthrough business models : drug development for rare and neglected diseases and individualized therapies : workshop summary / / Theresa Wizemann, Sally Robinson, and Robert Giffin ; Forum on Health Sciences Policy, Institute of Medicine of the National Academies
| Breakthrough business models : drug development for rare and neglected diseases and individualized therapies : workshop summary / / Theresa Wizemann, Sally Robinson, and Robert Giffin ; Forum on Health Sciences Policy, Institute of Medicine of the National Academies |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Washington, D.C., : National Academies Press, 2009 |
| Descrizione fisica | 1 online resource (149 p.) |
| Disciplina | 615/.19 |
| Altri autori (Persone) |
WizemannTheresa M
RobinsonSally GiffinRobert B |
| Soggetto topico |
Orphan drugs - Government policy - United States
Pharmaceutical policy - United States Drugs - Design - United States |
| ISBN |
0-309-17816-9
1-282-08355-4 9786612083556 0-309-12089-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction and overview -- Current model for financing drug development : from concept through approval -- The Food and Drug Administration's Orphan Drug Program -- Diverse funding models -- Strategies for facilitating sharing of research materials and data -- Strategies of navigation intellectual property -- Strategies for facilitating clinical trials -- Summary. |
| Record Nr. | UNINA-9910812068203321 |
| Washington, D.C., : National Academies Press, 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Challenges for the FDA [[electronic resource] ] : the future of drug safety : workshop summary / / Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies ; Leslie Pray and Sally Robinson, rapporteurs
| Challenges for the FDA [[electronic resource] ] : the future of drug safety : workshop summary / / Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies ; Leslie Pray and Sally Robinson, rapporteurs |
| Pubbl/distr/stampa | Washington, DC, : National Academies Press, c2007 |
| Descrizione fisica | xvii, 109 p. : ill |
| Altri autori (Persone) |
PrayLeslie A
RobinsonSally |
| Soggetto topico |
Drugs - United States - Testing
Drugs - United States - Safety measures |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-281-09355-6
9786611093556 0-309-10987-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910451934203321 |
| Washington, DC, : National Academies Press, c2007 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
